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Ayurveda emphasizes on healthy living with good food 
practices and a healthy life style. Ayurveda being an 
ancient science promotes to follow Dinacharya and 
Rutucharya which enables one to lead a healthy life 
without any disease. But due to modernization and 
changing pace of life, everything has changed be it the 
food we consume or the professions we are doing. 
Technological  inventions  have  lessened  the physical 
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activities and has enforced one to adopt to sedentary 
life style in urban culture. It is also not untrue even at 
rural areas. More usage of gadgets confines one to 
adopt to sedentary life style. This leads to a plethora 
of diseases affecting the mankind and one among 
them is Vatarakta. 
Vayurvivruddho Vruddhena Raktena Avaritaha Pathi 
Kritsnam Sandhushayet Raktam Tat gneyam 
Vatashonitam. 
Vatarakta is one of the disease conditions where 
vitiated Vata and Rakta obstruct one another and 
accumulate in the smaller joints causing painful 
condition like Shotha, Twak Vaivarnyata, Shoola, 
Kandu and Daha. Vata and Rakta are the two entities 
which move all over the body and cause the 
symptoms of the said disease. Vatarakta can be 
compared to gouty Arthritis a condition where uric 
acid crystal accumulates in the joints and causes 
deformity in the joint. 
A B S T R A C T  
Background: Vatarakta is one of the disease conditions that is manifested due to vitiated Vata and 
Rakta. According to Acharya Charaka it is also called as Khudavata because of its affliction in smaller 
joints. The disease is compared to gouty arthritis which is manifested due to accumulation of uric acid 
crystals in the joints. Virechana and Basti are the Shodhana Chikitsa indicated in Vatarakta. Aims and 
Objectives: Hence the present study was taken to compare the efficacy of Virechana and Basti in 
managing Vatarakta Vyadhi and to compare their effect in reducing serum uric acid level. Materials 
and Methods: In the present study 100 subjects were randomly selected with 50 patients in each 
group. Group A was treated with Nimbamritadi Eranda Taila Virechana and Group B with Dashamoola 
Kashaya Nirooha Basti and Balaguduchyadi Taila Anuvasana Basti in Kala Basti Krama. The efficacy of 
the therapy was assessed based on the subjective symptoms like Sandhigraha, Sandhishoola, 
Vaivarnyata and Sparshasahatwa and objective parameters like serum uric acid level and Mac gills 
pain scale. Result: Basti Chikitsa was significant in reducing serum uric acid level as compared to 
Virechana which was not significant. Conclusion: It was concluded that Ardhamatrika Niruha Basti 
was more effective in reducing serum uric acid level as compared to Virechana. 
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Recent reports of the prevalence and incidence of 
gout vary widely according to the population studied 
indicates that it is more common in men than in 
women. The prevalence of gout increases with age, 
with the highest prevalence observed in people over 
40. The global burden of gout is substantial and seems 
to be increasing in many parts of the world over the 
past 50 years. Developed countries tend to have a 
higher burden of gout than developing countries. 
Socioeconomic and dietary factors, as well as 
comorbidities and medications that can influence uric 
acid levels and facilitate MSU crystal formation, are 
also important in determining the risk of developing 
clinically evident gout. The condition now effects 4% 
of the population. 
Various Treatment modalities can be incorporated for 
the treatment of Vatarakta. Shamana and Shodhana 
Chikitsa can be effective in its treatment. In the 
present study an attempt is done to evaluate the 
efficacy of Virechana and Basti in reducing the uric 
acid level in gouty arthritis. 
AIMS AND OBJECTIVES 
1. Primary objective was to evaluate and compare 
the efficacy of Virechana and Ardhamatrika Basti 
in the management of Vatarakta. 
2. Secondary Objective was to assess the effect of 
Virechana and Basti on raised Uric acid level in 
gouty arthritis. 
MATERIALS AND METHODS 
▪ The Study was a randomized, Comparative single 
blind Study where patients were assigned into 
two groups Group A and Group B. 
▪ The patients attending the OPD of Kayachikitsa at 
Ayurveda Mahavidyalaya Hubli, with the history 
of Vatarakta and fulfilling the criteria of selection, 
were selected. 
▪ Before the starting of the clinical trial approval 
from Institutional ethical committee was 
obtained. Informed written consent from each 
patient willing to undergo the treatment was 
taken before the study. 
▪ The medicines, Panchatikta Guggulu Ghrita, 
Nimbamritadi Eranda Taila, Balaguduchyadi Taila, 
Dashamoola Kwatha Churna were procured from 
Pavaman Pharmaceuticals, Vijayapur.  
Inclusion Criteria  
▪ Subjects presenting with clinical features of 
Vataraktahara / Gouty Arthritis 
▪ Subjects of either sex between age group of 20-70 
yrs. 
▪ Subjects suitable for Basti Karma and Virechana 
Karma. 
▪ Subject showing the uric acid level above 6mg/dl 
(Above Biological Range). 
Exclusion Criteria 
▪ Subjects with uncontrolled diabetes, systemic 
disorders and endocrine disorders.                             
▪ Subjects with autoimmune disease of joints. 
▪ Subjects with infection and communicable 
diseases. 
▪ Subjects not suitable for Basti Karma and 
Virechana Karma. 
Investigations 
1. General Investigations. 
Hematological - Hemoglobin %, total leucocyte count 
(TLC), different leucocyte count (DLC), erythrocyte 
sedimentation rate and packed cell volume were 
carried out before the treatment. Random blood 
sugar was also done before the treatment. 
Serological - HIV (human immunodeficiency virus), 
HBsAg (hepatitis B surface antigen) were done before 
treatment only. 
Urine (routine - microscope) examination was done 
before the treatment. 
2. Specific Investigations. 
Serum Uric acid tests were done before and after the 
treatment. 
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Treatment Protocol 
In the present study, the patients were randomly 
divided into two groups (Group A & Group B)        
Interventions 
Group A: Virechana 
Hareetakyadi Choorna for Ama Pachana till the 
appearance of Nirama Lakshana. 




Snehapana was done with Panchatikta Ghruta 
Guggulu. On the first day subjects were given 
Hrasiyasi Matra of Sneha i.e. 30ml and based on the 
duration taken for digestion, the dose was increased 
each day And Soon After Samyak Snigdha Lakshanas 
Seen, The Snehapana Was Discontinued. 
Anupana - Ushnodhaka 
Kala - Ananna Kala 
Abhyanga - Abhyanga was given for three days by 
Bashpa Sweda till Swinna Lakshana is seen. 
Pradhana Karma 
Nimbamritaerandataila was administered as 
Virechana Yoga considering the Koshtha of the 
patient in the morning. Throughout the day patient 
was observed for Samyak Lakshana. 
Paschat Karma 
Samsarjana Karma was followed based on Pravara, 
Madhyama, and Avara Shuddhi. 
Group B: Basti in Kala Basti Schedule 
Hareetakyadi Choorna for Ama Pachana till the 
appearance of Niramalakshana is attained. 
Dose - 5gm twice a day with Ushnodaka Anupana 
before Food. 
Poorva Karma 
Sthanika abhyanga with Balaguduchyaditaila. 
Sthanikaswedana with Ushnajala 
Laghu Ushna Anabhishyandhi Bhojana, before 
Anuvaasanabasti. 
Pradhana Karma 
In this study, Ardhamaatrikabasti was administered in 
a Kalabasti course, where in six Ardhamaatrikabasti 
will be administered on 2nd, 4th, 6th, 8th, 10th, 12th day 
in the morning, empty stomach along with five 
Anuvaasanabasti with Balaguduchyaditaila which was 
administered on 1st, 3rd, 5th, 7th, 9th, 11th, 13th,15th, 
16th, day in the afternoon, immediately after food. 
Pashchat Karma 
Advised to avoid Ashtamahadoshkarabhaavas. 
To have Ushna Laghu Abishyandhibhojana. 
This was advised to follow for 32 days. 
1st day A 2nd day N 3th day A 4th day N 
5th day A 6th day N 7th day A 8th day N 
9th day A 10th day N 11th day A 12th day N 
13th day A 14th day A 15th day A 16th day A 
N - Niruha   A - Anuvasana  
Assessment of Result 
The parameters of base line data on pre and post 
medication will be compared with gradations for 
assessment. Statistical tests will be applied and 
assessment will be made. 
Subjective parameters: 
▪ Grading of Symptoms (Assessment criteria) 
▪ Sandhi Graha (Stiffness of joint) 
▪ Sandhishoola (joint pain) 
▪ Shotha (inflammation) 
Objective parameters 
▪ Serum Uric Acid before and after treatment. 
▪ Vaivarnyata 
▪ Sparsha Asahatava (Tenderness) 
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▪ McGill pain scale for pain assessment 
Criteria for Assessment 
The efficacy of the therapy was assessed on the basis 
of reduction in severity of the symptoms like 
Sandhigraha, Sandhishoola, Sparshasahatwa, 
Vaivarnyata, Shotha and the value of serum uric acid 
before and after treatment. 
To assess the overall response of therapies, Mac gills 
pain scale was used. 
Statistical estimation of results 
The obtained data was analyzed for statistical 
significance using paired T test within the groups and 
unpaired T test in between the groups. The level of 
“p” between 0.05 to0.01 and P<0.001 was considered 
as statistically significant and highly significant, 
respectively. If the calculated “t” values was more 
than 0.05 (P>0.05), results were taken as insignificant. 
OBSERVATIONS AND RESULTS 
Table 1: Comparisons Between Groups A and B in 


























































HS: Highly significant 
Table 2: Comparisons Between Groups A and B in 
























































NS: Insignificant, HS: Highly significant 



























































NS: Insignificant, HS: Highly significant 
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Table 4: Comparisons Between Groups A and B in 
























































NS : Insignificant, HS: Highly significant 
Table 5: Comparisons Between Groups A and B in 

























































NS : Insignificant, HS: Highly significant 
Table 6: Comparisons Between Groups A and B in Mc 
























































NS: Insignificant, HS: Highly significant 
Effect of therapies between the two groups. 
Sandhi Graha 
Effect of treatment on group A on Sandhi Graha: The 
mean before treatment is 2.16 and it has reduced to 
0.98 after treatment. It was found highly significant 
result at the end of the treatment with p value being < 
0.001. 
Effect of treatment on group B on Sandhi Graha: The 
mean before treatment is 2.64 and it has reduced to 
0.66 after treatment. It was found highly significant 
result at the end of the treatment with p value being < 
0.001. In this way Basti Karma showed better result 
than Virechana Karma. 
Sandhi Shoola 
Effect of treatment on group A on Sandhi Shoola: The 
mean before treatment is 1.96 and it has reduced to 
0.98 after treatment. It was found non-significant 
result at the end of the treatment with p value being < 
0.101. 
Effect of treatment on group B on Sandhi Shoola: The 
mean before treatment is 2.22 and it has reduced to 
0.32 after treatment. It was found highly significant 
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result at the end of the treatment with p value being < 
0.001. This shows that Virechana was better than 
Basti. 
Sandhi Shotha 
Effect of treatment on group A on Sandhi Shotha: The 
mean before treatment is 0.86 and it has reduced to 
0.24 after treatment. It was found non-significant 
result at the end of the treatment with p value being < 
0.227. 
Effect of treatment on group B on Sandhi Shotha: The 
mean before treatment is 0.60 and it has reduced to 
0.16 after treatment. It was found non-significant 
result at the end of the treatment with p value being < 
0.322. 
Vaivarnyata 
Effect of treatment on group A on Sandhi Shoola: The 
mean before treatment is 1.28 and it has reduced to 
0.42 after treatment. It was found non-significant 
result at the end of the treatment with p value being < 
0.568. 
Effect of treatment on group B on Sandhi Shoola: The 
mean before treatment is 1.18 and it has reduced to 
0.16 after treatment. It was found not significant 
result at the end of the treatment with p value being < 
0.004. This shows that Virechana was better than 
Basti. 
Sparsha Asahatava 
Effect of treatment on group A on Sparsha Asahatwa: 
The mean before treatment is 1.58 and it has reduced 
to 0.44 after treatment. It was found non-significant 
result at the end of the treatment with p value being < 
0.254. 
Effect of treatment on group B on Sparsha Asahatwa: 
The mean before treatment is 1.82 and it has reduced 
to 0.18 after treatment. It was found not significant 
result at the end of the treatment with p value being < 
0.030. This shows that Virechana was better than 
Basti. 
Uric acid 
Effect of treatment on group A on Uric acid: The mean 
before treatment is 8.48 and it has reduced to 4.74 
after treatment. It was found non-significant result at 
the end of the treatment with p value being < 0.434. 
Effect of treatment on group B on Uric acid: The mean 
before treatment was8.72 and it has reduced to 5.86 
after treatment. It was found give highly significant 
result at the end of the treatment with p value being 
0.001. In this way Basti was better than Virechana 
Karma. 
Mac gills pain scale 
Effect of treatment on group A: The mean before 
treatment was 3.06 and it has reduced to 0.82 after 
treatment. It was found non-significant result at the 
end of the treatment with p value being <0.180 
Effect of treatment on group B: The mean before 
treatment was 2.80 and it has reduced to 1.40 after 
treatment. It was found give highly significant result 
at the end of the treatment with p value being 0.001. 
In this way Basti was better than Virechana Karma. 
DISCUSSION 
Sandhi (Joint) is a very important structure in the body 
of human being - without the joints, the locomotion; 
the characteristic feature of the animals would not 
have been possible. Vatarakta is one of the prominent 
disorders affecting the joints. As per the 
symptomatology and pathogenesis Vatarakta can be 
correlated to Gouty Arthritis in modern science 
because of the presenting symptoms like Sandhi 
Shula, Sandhi Shotha, Vaivarnata, etc.  
The movement of Vatadosha is inhibited by the 
unique pathology of Raktamargavarana in Vatarakta. 
This in turn initially manifest with certain clinical signs 
and symptoms in the form of Purvarupa. Alteration in 
the colour and texture of the skin in the affected part, 
alteration in sweating, alteration in the sensation, 
different forms of pain and similar other 
manifestations are listed as Purvarupa. 
Depending upon the superficial or deeper Dhatu 
involved, the Vatarakta is of two types. When the 
pathogenesis of Vatarakta is limited to Twak and 
Mamsa Dhatu it is regarded as Utthana (Anavagadha) 
Vatarakta. Involvement of deeper Dhatu like Asthi 
Uma A. Patil et al. Role of Virechana and Basti in the management of Gouty Arthritis 
ISSN: 2456-3110                                                   ORIGINAL ARTICLE Sept-Oct 2021 
 
Journal of Ayurveda and Integrated Medical Sciences | Sept - Oct 2021 | Vol. 6 | Issue 5 7 
 
Majja and Sandhi signifies the Gambhira (Avagadha) 
Vatarakta. A third variety of Ubhayashrita Vatarakta 
is also mentioned in literature where in both the 
superficial as well as deeper Dhatus are affected. 
Vatarakta is a progressive disorder.            
The symptoms like Kandu, Daha, Ruka, Ayama, Toda, 
Sphurana, Shyava/Rakta Tvaka and such other 
symptoms probably limited to the Twak indicates the 
Utthana Vatarakta. Persistent hard swelling of the 
affected part, suppurations, involvement of Sandhi 
Asthi and Majja, deformities like Vakrata, Khanja and 
Pangu all these point towards the Gambhira 
Vataratka. 
Various Chikitsa modalities are explained for the 
management of Vatarakta i.e., Raktamokshana, Vasti, 
Virechana, Shamanaoushadhi, Nidana Parivarjana. 
Shodhana Chikitsa gives good results compared to 
Shamana therapy.  In case of Vatarakta, Sandhis 
(Asthi Dhatu) are affected which is Madhyama 
Rogamarga. 
In this study, Hareetakyadi Churna was selected for 
Ama Pachana because it is Deepana and Pachana in 
nature. The ingredient of this Choorna all are 
Agnideepaka and Mruduvirechaka. Hareetaki and 
Amalaki are Srotoshodhaka. By their Mruduvirechaka 
and Srotoshodhaka property Hareetaki and Amalaki 
does the Srotoshodhana and hence clear the Srotas. 
Hence Hareetakyadi Choorna was used as 
Agnideepana Oushadha before Virechana. 
Ama Pachana before Virechana 
Prior to administration of Snehapana, the body should 
have Nirama stage, which is achieved by Ama 
Pachana and Agni Deepana. The reason behind it is 
that, the qualities of Snehana Dravya need a platform 
for its action. These drugs which are digestives and 
carminatives stimulate enzymatic secretions, HCL 
secretions, pancreatic and bile secretions, thereby 
proper assimilation of Sneha will occur. Hence the 
Hareetakyadi Churna regulates the function of 
Shamana and Apana Vata and Kledaka Kapha. With 
this treatment it was observed that most of the 
patients attained Samyak Mala Pravrutti. 
Snehapana 
The best suited Sneha for Vatarakta is Pancha Tikta 
Guggulu Ghrita. This soothes and lubricates the Srotas 
and disintegrates the accumulated Dosha and brings 
to the Koshta for their easy elimination. Nimba, 
Guduchi, Patola all are Tikta Rasatmaka and they are 
Swedhagna, Kandughna, Kushtaghna. Nimba is 
Krimihara. Patola by its Ushna and Snigdha Guna 
reduces the Rookshata. Tikta Rasa is formed by Vayu 
and Prithvi Mahabhoota and Rooksha, Sheeta and 
Laghu Gunatmaka. It is Kleda Shoshaka. By its Mrudu 
and Vishada Guna it enhances Vata. Guggulu is having 
anti-inflammatory property and hence is beneficial in 
Sandhi and Asthi Majjagata Vikara.  
It mainly acts on body wastes (Kleda), Fat (Meda), 
Lasika (plasma), Rakta (blood), Pitta, Sweda (sweat) 
and Shleshma. Nimba has chemical composition of 
Nimbin. Nimbidin possesses significant dose 
dependent anti-inflammatory activity & significant 
anti-ulcer effect. Guduchi (Tinospora cordifolia) having 
Berberin & Tinosporin mainly acts as antioxidant & 
immune potentiating thus cell layers during disease 
pathology are improved by this drug. Vasa (Adhatoda 
vasica) the Vascicinone has anti- histaminic property 
as well as it is anti-oxidant & anti- inflammatory. 
Patola (Trichosanthes dioica) has anti-oxidant & 
Nidigdhika (Solanum xanthokarpum) has anti 
histaminic property. Guggulu (Commiphora mukul) 
has excellent property to act on Vikrut Kleda 
(abnormal body wastes) & Meda (fat), Mamsa Dhatu 
(flesh) as it has Katu, Tikta, Kashaya, Madhura Rasa, 
Ushna Veerya & Katu Vipak. Guggulu stimulates body 
activity to build up immune system. Ghrita has 
lipophilic action so helps in ion transportation to a 
target organ. This lipophilic nature of Ghrita facilitates 
entry of drug into cell & its delivery to mitochondria, 
microsome and nuclear membrane. 
Abhyanga 
Acharya Charaka quotes the Sthana of Vayu is 
Sparshanedriya and Adhishtana of Sparshanedriya is 
Twacha. Massage acts on three systems namely blood 
vascular system, lymphatic system and nervous 
system. The lymphatic system and blood vascular 
Uma A. Patil et al. Role of Virechana and Basti in the management of Gouty Arthritis 
ISSN: 2456-3110                                                   ORIGINAL ARTICLE Sept-Oct 2021 
 
Journal of Ayurveda and Integrated Medical Sciences | Sept - Oct 2021 | Vol. 6 | Issue 5 8 
 
system are supplementary to each other. The 
lymphatic system offers an alternative route for the 
return of tissue fluid to the blood stream. By 
application of Taila in Abhyanga generates heat and 
thus stimulates lymphatic flow. 
In Vatarakta, Sandhi Shula, Sandhishotha, Daha etc. 
are seen. Abhyanga with Taila lessens vitiated Vata. 
The Veerya of the drug used in Taila for Abhyanga 
enters skin under the influence of Bhrajakagni. This 
helps to penetrate into deeper Dhatu, and potency of 
the drugs enters into all Srotas and exhibits its action. 
While mentioning the Kala of Abhyanga, Sushruta has 
stated that after 900 Matra the Sneha can reach 
Majja Dhatu. It signifies the action of Sneha on Asthi-
Majja Dhatu which are mainly involved in Vatarakta. 
Virechana 
Nimbamrita Eranda Taila was used for Virechana as 
generally Sneha Virechana Yoga is Mrudu in nature. It 
is Sukha Virechaka drug and acts as Pitta Shamaka 
and Vatanulomaka.      
Virechana Dravya act either by a bulk affect or by 
irritant or stimulant action on the intestinal wall and 
so excites the Auerbach’s plexus and cause increased 
peristalsis. The mucosa of the intestinal tract becomes 
extensively irritated and its rate of secretion becomes 
greatly enhanced. In addition, the mobility of the 
intestinal wall usually increases many folds. As a 
result, large quantities of fluid are made available for 
washing these irritating agents and at the same time 
strong propulsive movements propel this fluid 
forward.           
Basti 
Acharya Charaka and Vagbhata mentioned “Na Hi 
Vasti Samam Kinchit Vatarakta Chikitsitam” There is 
no other therapeutic measures equivalent to Vasti in 
treating Vatarakta. Vasti is considered as Agrya 
Oushada for Vata.  Sneha used in Basti helps in proper 
Gati of Vata brings Gatra Mardavata and removes 
Srotorodha. The Taila is having anti-inflammatory, and 
analgesic effect. Bala Guduchyadi Taila possess similar 
effectiveness in treating the inflammation seen in 
both acute and chronic Vatarakta. 
Studies have revealed that the studied plant extract 
produced significant reduction in uric acid level in 
both plasma and urine associated with both 
antioxidant and anti-inflammatory effects which may 
be due to the presence of phenolic compounds, 
unsaturated fatty acids, long chain fatty acids and 
phytosterols. Thus, Balaguduchyadi Taila is acting at 
the level of Rakta, Asthi and Majja Dhatu. 
CONCLUSION 
The disease Vatarakta is due to vitiated Vata and 
Rakta the entities which move all over the body get 
obstructed by one another and get accumulated in 
the smaller joints leading to the symptoms of 
Sandhishoola, Sandhigraha, Sparshasahatwa, Twak 
Vaivarnyata. This disease is correlated to Gouty 
Arthritis, which is manifested due to accumulation of 
Monosodium Urate crystals in the joints which causes 
pain in the joints, and causing arthropathy. The 
accumulation of uric acid is what differentiates it from 
other joint disorders. Uric acid is a metabolic waste 
formed by excessive consumption of purine rich food. 
As uric acid is a metabolic waste Shodhana Chikitsa 
would be effective in reducing uric acid. According to 
the classics, Virechana, Basti, Raktamokshana are the 
treatment modalities effective to treat Vatarakta. In 
this study Virechana with Nimbamrita Eranda Taila, 
and Basti with Dashamoola Kashaya and 
Balaguduchyadi Taila were compared for their 
efficacy in reducing the Uric acid levels. Compared to 
Virechana Chikitsa,  Basti was effective in reducing the 
uric acid level.  
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